Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis

Abstract

p53 protein is a sequence-specific transcriptional activator which induces the expression of a number of cellular genes involved in different metabolic pathways. We report that the computer-selected sequence in human and mouse C-Ha-Ras gene confers to a reporter gene the ability to be directly transactivated by wild-type p53 either overexpressed or activated in response to a cellular stress. By analysing human transformed cell lines, we showed, at both mRNA and protein level, that the endogenous c-Ha-Ras gene expression is positively regulated by wt p53 protein. The stimulation of c-Ha-Ras gene expression in Saos-2Ts cells by a temperature shift down to the permissive temperature for the p53-wt conformation is associated with a significant increase in the activated form of p21c-Ha-Ras protein. Furthermore, in human transformed cell lines, the transient expression of a dominant interfering mutant of c-Ha-Ras greatly reduced the ability of p53 to induce apoptosis and inhibited the p53-dependent transactivation. This is due, at least in part, to a decrease in the protein (but not mRNA) level of the transiently expressed p53, indicating that inactivation of p21c-Ha-Ras signalling pathways led to a specific degradation of p53 protein. We therefore suggest that, by inducing c-Ha-Ras, p53 activates a positive feedback loop that counteracts the negative feedback loop mediated by Mdm2.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Aktas H, Cai H and Cooper GM. . 1997 Mol. Cell. Biol. 17: 3850–3857.

  • Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH. . 1998 Nature 395: 124–125.

  • Bourdon JC, Deguin-Chambon V, Lelong JC, Dessen P, May P, Debuire B and May E. . 1997 Oncogene 14: 85–94.

  • Brown K, Bailleul B, Ramsden M, Fee F, Krumlauf R and Balmain A. . 1988 Mol. Carcinogen. 1: 161–170.

  • Cadoret A, Bertrand F, Baron-Delage S, Levy P, Courtois G, Gespach C, Capeau J and Cherqui G. . 1997 Oncogene 14: 1589–1600.

  • Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ. . 1998 Oncogene 17: 1395–1413.

  • Chiloeches A, Paterson HF, Marais R, Clerk A, Marshall CJ and Sugden PH. . 1999 J. Biol. Chem. 274: 19762–19770.

  • Chomczyinski P and Sacchi N. . 1987 Anal. Biochem. 162: 156–159.

  • Crawford L, Leppard K, Lane D and Harlow E. . 1982 J. Virol. 42: 612–620.

  • de Rooij J and Bos JL. . 1997 Oncogene 14: 623–625.

  • Delphin C and Baudier J. . 1994 J. Biol. Chem. 269: 29579–29587.

  • Delphin C, Huang KP, Scotto C, Chapel A, Vincon M, Chambaz E, Garin J and Baudier J. . 1997 Eur. J. Biochem. 245: 684–692.

  • El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B. . 1992 Nat. Genet. 1: 45–49.

  • El-Deiry WS, Tokino T, Velculescu VE, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.

  • Feig LA and Cooper GM. . 1988 Mol. Cell. Biol. 8: 3235–3243.

  • Funk WD, Pak DT, Karas RH, Wright WE and Shay JW. . 1992 Mol. Cell. Biol. 12: 2866–2871.

  • Gannon JV, Greaves R, Iggo R and Lane DP. . 1990 EMBO J. 9: 1595–1602.

  • Herrmann C, Martin GA and Wittinghofer A. . 1995 J. Biol. Chem. 270: 2901–2905.

  • Hu MC, Qiu WR and Wang YP. . 1997 Oncogene 15: 2277–2287.

  • Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 8292–8297.

  • Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B. . 1991 Science 252: 1708–1711.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Lane DP and Hall PA. . 1997 Trends Biochem. Sci. 22: 372–374.

  • Leone G, Degregori J, Sears R, Jakoi L and Nevins JR. . 1997 Nature 387: 422–426.

  • Levine AJ. . 1997 Cell 88: 323–331.

  • May E, Mouriesse H, May-Levin F, Contesso G and Delarue JC. . 1989 Oncogene 1037–1042.

  • May P and May E. . 1999 Oncogene 18: 7621–7636.

  • Mazzoni IE, Said FA, Aloyz R, Miller FD and Kaplan D. . 1999 J. Neurosci. 19: 9716–9727.

  • Milne DM, Campbell DG, Caudwell FB and Meek DW. . 1994 J. Biol. Chem. 269: 9253–9260.

  • Milne DM, Campbell LE, Campbell DG and Meek DW. . 1995 J. Biol. Chem. 270: 5511–5518.

  • Miyashita T and Reed JC. . 1995 Cell 80: 293–299.

  • Olson MF, Paterson HF and Marshall CJ. . 1998 Nature 394: 295–299.

  • Omilli F, Ernoult-Lange M, Borde J and May E. . 1986 Mol. Cell. Biol. 6: 1875–1885.

  • Palmero I, Pantoja C and Serrano M. . 1998 Nature 395: 125–126.

  • Parada LF, Tabin CJ, Shih C and Weinberg RA. . 1982 Nature 297: 474–478.

  • Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, Decaprio JA and Ewen ME. . 1997 Nature 386: 177–181.

  • Pomerantz J, Schreiberagus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordoncardo C and Depinho RA. . 1998 Cell 92: 713–723.

  • Romano JW, Ehrhart JC, Duthu A, Kim CM, Appella E and May P. . 1989 Oncogene 4: 1483–1488.

  • Ronca F, Chan SL and Yu VC. . 1997 J. Biol.Chem. 272: 4252–4260.

  • Schweighoffer F, Cai H, Chevallier-Multon MC, Fath I, Cooper G and Tocque B. . 1993 Mol. Cell. Biol. 13: 39–43.

  • Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW. . 1997 Cell 88: 593–602.

  • Shaulian E, Haviv I, Shaul Y and Oren M. . 1995 Oncogene 10: 671–680.

  • Smart P, Lane EB, Lane DP, Midgley C, Vojtesek B and Lain S. . 1999 Oncogene 18: 7378–7386.

  • Spandidos DA, Zoumpourlis V, Zachos G, Toas SH and Halazonetis TD. . 1995 Int. J. Oncol. 7: 1029–1034.

  • Stephen CW, Helminen P and Lane DP. . 1995 J. Mol. Biol. 248: 58–78.

  • Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. . 1998 EMBO J. 17: 5001–5014.

  • Takenaka I, Morin F, Seizinger BR and Kley N. . 1995 J. Biochem. 270: 5405–5411.

  • Tegtmeyer P, Schwartz M, Collins JK and Rundell K. . 1975 J. Virol. 16: 168–178.

  • Telliez J-B, Plumb M, Balmain A and Vailleul B. . 1995 Mol. Carcinogen. 12: 137–145.

  • Tokino T, Thiagalingam S, El-Deiry WS, Waldman T, Kinzler K and Vogelstein B. . 1994 Hum. Mol. Genet. 3: 1537–1542.

  • Yamato K, Yamamoto M, Hirano Y and Tsuchida N. . 1995 Oncogene 11: 1–6.

  • Yonish-Rouach E, Bordé J, Gotteland M, Mishal Z, Viron A and May E. . 1994 Cell Death Differ. 1: 39–47.

  • Yonish-Rouach E, Deguin V, Zaitchouk T, Breugnot C, Mishal Z, Jenkins JR and May E. . 1995 Oncogene 11: 2197–2205.

  • Youmell M, Park SJ, Basu S and Price BD. . 1998 Biochem. Biophys. Res. Commun. 245: 514–518.

  • Zhang W, Randhawa GS, Gau JP, Shay JW and Deisseroth AB. . 1995 Int. J. Oncol. 7: 1021–1028.

  • Zhang YP, Xiong Y and Yarbrough WG. . 1998 Cell 92: 725–734.

Download references

Acknowledgements

We are grateful to A Atfi, R Busca, M Levrero, M Oren, T Soussi and B Vogelstein for providing the plasmids used in this study, K Yamato for the Saos-2Ts and Saos-Neo cell lines, S Lain for SKNSH-DDp53 and SKNSH-CMVNeo cell lines and D Lane for providing DO7 hybridoma cells. We are very grateful to JC Lelong for providing us with baculovirus purified p53 protein. We wish to thank A Atfi for helpful discussions and many insightful comments and P May and V Bouvard for critical reading of the manuscript. This work was supported by a grant from the ‘Association pour la Recherche sur le Cancer’ (ARC), by grant CT94002 from European Commission and by a grant from EDF. V Deguin-Chambon was supported by a fellowship from the ‘Ligue contre le Cancer – comité régional de la Vendée’ and the ARC. JC Bourdon was supported by a fellowship from the ARC and the ‘Fondation pour la Recherche Medicale’.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deguin-Chambon, V., Vacher, M., Jullien, M. et al. Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis. Oncogene 19, 5831–5841 (2000). https://doi.org/10.1038/sj.onc.1203960

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203960

Keywords

This article is cited by

Search

Quick links